Doctor: Dr. Doaa El Demerdash

Dr. Doaa El Demerdash

Dr. Doaa El Demerdash   Send Enquiry  Chat

Get response within 24hrs

Haemetologist | Cairo | Egypt
| 10 years Years of Experiences

As-Salam International Hospital, Cairo

  • Dr. Doaa El Demerdash is a Lecturer in Internal Medicine and Clinical Haematology at Cairo University, Egypt. She is a highly respected medical expert who is deeply committed to teaching, research, and patient care.
  • Dr. El Demerdash has dual MD degrees in Internal Medicine and Clinical Haematology, demonstrating her significant knowledge in both areas. She is also a Fellow of the Royal College of Physicians of Edinburgh (FRCP Edin.), which recognises her advanced clinical abilities and commitment to exceptional medical care.
  • Her professional ties demonstrate her active involvement in the worldwide medical community. Dr. El Demerdash is an active member of the European Haematology Association (EHA), the Pan Arab Haematology Association (PAHA), and the International Society of Thrombosis and Haemostasis (ISTH). These affiliations demonstrate her engagement in promoting haematology on a regional and worldwide scale.
  • Dr. El Demerdash now works as a Haematology Consultant at Assalam International Hospital, MISR International Hospital, and Almanial Hospitals. Her responsibilities at these premier institutions include identifying and treating a wide spectrum of haematological illnesses, using her significant knowledge and expertise to enhance patient outcomes.
  • Dr. El Demerdash also participates in the Young Researcher Group at Cairo University’s Faculty of Medicine. She fosters new academics and collaborates to ground-breaking research projects aimed at advancing medical knowledge and enhancing patient care.
  • Blood Transfusion
  • Bone Marrow Transplant
  • Stem Cell Transplant
  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Immunotherapy
  • Iron Chelation Therapy
  • Erythropoiesis-Stimulating Agents (ESAs)
  • Platelet Transfusion
  • Intravenous Immunoglobulin (IVIG)
  • Anticoagulation Therapy
  • Phlebotomy
  • Hydroxyurea Therapy
  • Thrombopoietin Receptor Agonists
  • Plasma Exchange (Plasmapheresis)
  • Gene Therapy
  • Corticosteroid Therapy
  • Leukapheresis
  • Monoclonal Antibody Therapy

Related News Articles:

No Related News Articles

Related Patient Stories:

No Related Patient Stories